BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12877588)

  • 21. Novel platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases: synthesis, crystal structure and cytotoxic activities.
    Neves AP; da Silva GB; Vargas MD; Pinheiro CB; Visentin Ldo C; Filho JD; Araújo AJ; Costa-Lotufo LV; Pessoa C; de Moraes MO
    Dalton Trans; 2010 Nov; 39(42):10203-16. PubMed ID: 20871881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity of 2,2':6',2' '-terpyridineplatinum(II) complexes against human ovarian carcinoma.
    Lowe G; Droz AS; Vilaivan T; Weaver GW; Park JJ; Pratt JM; Tweedale L; Kelland LR
    J Med Chem; 1999 Aug; 42(16):3167-74. PubMed ID: 10447962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic palladium(II) complexes of 8-aminoquinoline derivatives and the interaction with human serum albumin.
    Yan L; Wang X; Wang Y; Zhang Y; Li Y; Guo Z
    J Inorg Biochem; 2012 Jan; 106(1):46-51. PubMed ID: 22112839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palladium and platinum 3,5-diacetyl-1,2,4-triazol bis(thiosemicarbazones): chemistry, cytotoxic activity and structure-activity relationships.
    Matesanz AI; Souza P
    J Inorg Biochem; 2007 Feb; 101(2):245-53. PubMed ID: 17097146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and in vitro antitumor activity of platinum acetonimine complexes.
    Boccarelli A; Intini FP; Sasanelli R; Sivo MF; Coluccia M; Natile G
    J Med Chem; 2006 Jan; 49(2):829-37. PubMed ID: 16420068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of the leaving group for antitumor activity of new platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; Contaldi S; den Dulk H; Monari M; Brouwer J; Jaehde U; Kalayda GV; Reedijk J
    J Inorg Biochem; 2009 Dec; 103(12):1602-8. PubMed ID: 19783310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
    Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
    Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization and biological activity of Pt(II) and Pt(IV) complexes with 5-methyl-5(4-pyridyl)-2,4-imidazolidenedione.
    Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ferdinandov D; Konstantinov S; Ivanov D
    Eur J Med Chem; 2008 May; 43(5):958-65. PubMed ID: 17707952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
    Vrzal R; Starha P; Dvorák Z; Trávnícek Z
    J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
    Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
    J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans-platinum(IV) complexes with functionalized pyridines.
    Rakić GM; Grgurić-Šipka S; Kaluđerović GN; Bette M; Filipović L; Aranđelović S; Radulović S; Tešić ZLj
    Eur J Med Chem; 2012 Sep; 55():214-9. PubMed ID: 22858225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity.
    Fisher DM; Bednarski PJ; Grünert R; Turner P; Fenton RR; Aldrich-Wright JR
    ChemMedChem; 2007 Apr; 2(4):488-95. PubMed ID: 17340669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemistry, antiproliferative activity and low nephrotoxicity of 3,5-diacetyl-1,2,4-triazol bis(4N-thiosemicarbazone) ligands and their platinum(II) complexes.
    Matesanz AI; Joie C; Souza P
    Dalton Trans; 2010 Aug; 39(30):7059-65. PubMed ID: 20571622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New synthetic route to [bis-1,2-(aminomethyl)benzene]dichloroplatinum(II) complexes, screening for cytotoxic activity in cisplatin-sensitive and resistant human cancer cell lines, and reaction with glutathione.
    Rinke K; Grünert R; Bednarski PJ
    Pharmazie; 2001 Oct; 56(10):763-9. PubMed ID: 11683118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes.
    Friebolin W; Schilling G; Zöller M; Amtmann E
    J Med Chem; 2004 Apr; 47(9):2256-63. PubMed ID: 15084124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.